In Vivo Impact on Rabbit Subchondral Bone of Viscosupplementation with a Hyaluronic Acid Antioxidant Conjugate

Overview

Journal BMC Musculoskelet Disord

Publisher Biomed Central

Specialties Orthopedics
Physiology

Date 2024 Dec 20

PMID 39702245

Authors

R Rieger

S Kaderli

C Boulocher

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to assess the effects of an antioxidant-conjugated Hyaluronic Acid (HA), specifically HA-4-aminoresorcinol (HA4AR), on articular cartilage and subchondral bone in osteoarthritis (OA). We conducted a comparative analysis between HA4AR and a commercially available high molecular weight HA formulation in a rabbit model of OA.

Materials And Methods: Eighteen rabbits underwent unilateral anterior cruciate ligament transection (ACLT) and were divided into three groups of six: Saline-group, HA-group, and HA4AR-group, based on the type of intra-articular injection received. Additionally, eight non-operated contralateral knees served as reference points (Contralateral-group). Six weeks post-surgery, iodine-enhanced micro-computed tomography imaging was used to evaluate articular cartilage volume and thickness, and to assess subchondral bone microarchitecture and mineral density.

Results: Cartilage thickness in both the HA and HA4AR groups was comparable to that of the Contralateral group. Notably, there was a significant reduction in subchondral bone plate tissue mineral density in the HA-group when compared to both the HA4AR and Saline groups (p < 0.05). However, no significant differences in trabecular subchondral bone microarchitectural parameters and mineral densities were observed between the HA4AR-group and the Saline-group. When compared to the Contralateral, Saline, and HA4AR groups, the HA-group exhibited a marked decrease in subchondral bone plate tissue mineral density (p < 0.05). Additionally, a significant reduction in trabecular bone volume fraction was noted in the HA-group compared to the Contralateral-group (p < 0.05).

Conclusions: The HA-4AR hydrogel demonstrated significant preservation of subchondral bone plate tissue mineral density compared to HA alone, while other bone microarchitectural parameters remained largely unchanged. These findings indicate that HA-4AR may provide enhanced osteoprotective benefits in the treatment of osteoarthritis.

References

Kaderli S, Viguier E, Watrelot-Virieux D, Roger T, Gurny R, Scapozza L . Efficacy study of two novel hyaluronic acid-based formulations for viscosupplementation therapy in an early osteoarthrosic rabbit model. Eur J Pharm Biopharm. 2015; 96:388-95. DOI: 10.1016/j.ejpb.2015.09.005. View

Duan X, Sandell L, Chinzei N, Holguin N, Silva M, Schiavinato A . Therapeutic efficacy of intra-articular hyaluronan derivative and platelet-rich plasma in mice following axial tibial loading. PLoS One. 2017; 12(4):e0175682. PMC: 5391072. DOI: 10.1371/journal.pone.0175682. View

Hintz M, Ernest T, Kondrashov P . Use of the Contralateral Knee as a Control in the Destabilization of Medial Meniscus Osteoarthritis Rat Model. Mo Med. 2020; 117(5):457-460. PMC: 7723149. View

Adebayo O, Ko F, Goldring S, Goldring M, Wright T, van der Meulen M . Kinematics of meniscal- and ACL-transected mouse knees during controlled tibial compressive loading captured using roentgen stereophotogrammetry. J Orthop Res. 2016; 35(2):353-360. PMC: 5349862. DOI: 10.1002/jor.23285. View

Burr D, Gallant M . Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012; 8(11):665-73. DOI: 10.1038/nrrheum.2012.130. View

Findlay D, Kuliwaba J . Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res. 2016; 4:16028. PMC: 5028726. DOI: 10.1038/boneres.2016.28. View

Conrozier T, Mathieu P, Rinaudo M . Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress. Rheumatol Ther. 2016; 1(1):45-54. PMC: 4883257. DOI: 10.1007/s40744-014-0001-8. View

Kaderli S, Boulocher C, Pillet E, Watrelot-Virieux D, Roger T, Viguier E . A novel oxido-viscosifying Hyaluronic Acid-antioxidant conjugate for osteoarthritis therapy: biocompatibility assessments. Eur J Pharm Biopharm. 2014; 90:70-9. DOI: 10.1016/j.ejpb.2014.10.016. View

Batiste D, Kirkley A, Laverty S, Thain L, Spouge A, Holdsworth D . Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT. Osteoarthritis Cartilage. 2004; 12(12):986-96. DOI: 10.1016/j.joca.2004.08.010. View

10.

Piuzzi N, Midura R, Muschler G, Hascall V . Intra-articular hyaluronan injections for the treatment of osteoarthritis: perspective for the mechanism of action. Ther Adv Musculoskelet Dis. 2018; 10(2):55-57. PMC: 5784477. DOI: 10.1177/1759720X17752038. View

11.

Laverty S, Girard C, Williams J, Hunziker E, Pritzker K . The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage. 2010; 18 Suppl 3:S53-65. DOI: 10.1016/j.joca.2010.05.029. View

12.

Yang K, Wu C, Chen W, Sumi S, Huang T . l-Glutathione enhances antioxidant capacity of hyaluronic acid and modulates expression of pro-inflammatory cytokines in human fibroblast-like synoviocytes. J Biomed Mater Res A. 2016; 104(8):2071-9. DOI: 10.1002/jbm.a.35729. View

13.

Vignon E, Bejui J, Mathieu P, Hartmann J, Ville G, EVREUX J . Histological cartilage changes in a rabbit model of osteoarthritis. J Rheumatol. 1987; 14 Spec No:104-6. View

14.

Pontes-Quero G, Garcia-Fernandez L, Aguilar M, Roman J, Perez Cano J, Vazquez-Lasa B . Active viscosupplements for osteoarthritis treatment. Semin Arthritis Rheum. 2019; 49(2):171-183. DOI: 10.1016/j.semarthrit.2019.02.008. View

15.

Tiraloche G, Girard C, Chouinard L, Sampalis J, Moquin L, Ionescu M . Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum. 2005; 52(4):1118-28. DOI: 10.1002/art.20951. View

16.

Shirai T, Kobayashi M, Nishitani K, Satake T, Kuroki H, Nakagawa Y . Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res. 2011; 29(10):1572-7. DOI: 10.1002/jor.21394. View

17.

Yoshimi T, Kikuchi T, Obara T, Yamaguchi T, Sakakibara Y, Itoh H . Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin Orthop Relat Res. 1994; (298):296-304. View

18.

Fajardo M, Di Cesare P . Disease-modifying therapies for osteoarthritis : current status. Drugs Aging. 2005; 22(2):141-61. DOI: 10.2165/00002512-200522020-00005. View

19.

Shen Q, Li J, Chan D, Sandy J, Takeuchi J, Ross R . Effect of intra-articular hyaluronan injection on inflammation and bone remodeling in the epiphyses and metaphyses of the knee in a murine model of joint injury. Am J Transl Res. 2019; 11(6):3280-3300. PMC: 6614662. View

20.

Pilloni A, Bernard G . The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res. 1998; 294(2):323-33. DOI: 10.1007/s004410051182. View